Negative regulation of NEP expression by hypoxia

Prostate

Volumn 73, Issue 7, 2013, Pages 706-714

  Mitra, Ranjana ^a,b   Chao, Olivia S ^a,b   Nanus, David M ^c   Goodman Jr , Oscar B ^a,b  

^a ROSEMAN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b NEVADA CANCER INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

hypoxia; hypoxia responsive elements; neutral endopeptidase

Indexed keywords

COBALT CHLORIDE; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN UMBILICAL VASCULAR ENDOTHELIAL CELL; HYPOXIA; MICROVASCULAR ENDOTHELIAL CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL HYPOXIA; CHROMATIN IMMUNOPRECIPITATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; NEPRILYSIN; PROSTATE; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84876280635     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22613     Document Type: Article

References (30)

1. Shipp MA, Tarr GE, Chen CY, Switzer SN, Hersh LB, Stein H, Sunday ME, Reinherz EL,. CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 1991; 88: 10662-10666.
2. Turner AJ, Tanzawa K,. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 1997; 11: 355-364.
3. Horiguchi A, Chen DY, Goodman OB Jr, Zheng R, Shen R, Guan H, Hersh LB, Nanus DM,. Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis. Prostate Cancer Prostatic Dis 2008; 11: 79-87.
4. Goodman OB Jr, Febbraio M, Simantov R, Zheng R, Shen R, Silverstein RL, Nanus DM,. Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2. J Biol Chem 2006; 281: 33597-33605.
5. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM,. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 1998; 4: 50-57.
6. Usmani BA, Shen R, Janeczko M, Papandreou CN, Lee WH, Nelson WG, Nelson JB, Nanus DM,. Methylation of the neutral endopeptidase gene promoter in human prostate cancers. Clin Cancer Res 2000; 6: 1664-1670.
7. Iwase A, Shen R, Navarro D, Nanus DM,. Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins. J Biol Chem 2004; 279: 11898-11905.
8. Sumitomo M, Shen R, Walburg M, Dai J, Geng Y, Navarro D, Boileau G, Papandreou CN, Giancotti FG, Knudsen B, Nanus DM,. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. J Clin Invest 2000; 106: 1399-1407.
9. Sumitomo M, Milowsky MI, Shen R, Navarro D, Dai J, Asano T, Hayakawa M, Nanus DM,. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. Cancer Res 2001; 61: 3294-3298.
10. Osman I, Dai J, Mikhail M, Navarro D, Taneja SS, Lee P, Christos P, Shen R, Nanus DM,. Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression. Cancer 2006; 107: 2628-2636.
11. Wang Z, Yang D, Zhang X, Li T, Li J, Tang Y, Le W,. Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS ONE 2011; 6: e19229.
12. Carpenter TC, Stenmark KR,. Hypoxia decreases lung neprilysin expression and increases pulmonary vascular leak. Am J Physiol Lung Cell Mol Physiol 2001; 281: L941-L948.
13. Melchionna R, Romani M, Ambrosino V, D'Arcangelo D, Cencioni C, Porcelli D, Toietta G, Truffa S, Gaetano C, Mangoni A, Pozzoli O, Cappuzzello C, Capogrossi MC, Napolitano M,. Role of HIF-1alpha in proton-mediated CXCR4 down-regulation in endothelial cells. Cardiovasc Res 2010; 86: 293-301.
14. Semenza GL,. HIF-1: Upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010; 20: 51-56.
15. Cho J, Kim D, Lee S, Lee Y,. Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells. Mol Endocrinol 2005; 19: 1191-1199.
16. Bardos JI, Ashcroft M,. Negative and positive regulation of HIF-1: A complex network. Biochim Biophys Acta 2005; 1755: 107-120.
17. Mitra R, Guo Z, Milani M, Mesaros C, Rodriguez M, Nguyen J, Luo X, Clarke D, Lamba J, Schuetz E, Donner DB, Puli N, Falck JR, Capdevila J, Gupta K, Blair IA, Potter DA,. CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (+/-)-14,15-epoxyeicosatrienoic acid (EET). J Biol Chem 2011; 286: 17543-17559.
18. Dignam JD, Lebovitz RM, Roeder RG,. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-1489.
19. Gillies RJ, Gatenby RA,. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 2007; 26: 311-317.
20. Geller J, Sionit LR, Baird A, Kohls M, Connors KM, Hoffman RM,. In vivo and in vitro effects of androgen on fibroblast growth factor-2 concentrations in the human prostate. Prostate 1994; 25: 206-209.
21. Nishi N, Oya H, Matsumoto K, Nakamura T, Miyanaka H, Wada F,. Changes in gene expression of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostates. Prostate 1996; 28: 139-152.
22. Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP,. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate 2001; 49: 293-305.
23. Mazzucchelli R, Montironi R, Santinelli A, Lucarini G, Pugnaloni A, Biagini G,. Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients. Prostate 2000; 45: 72-79.
24. Lekas A, Lazaris AC, Deliveliotis C, Papatsoris AG, Lappas D, Patsouris E, Deliveliotis C,. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue. Anticancer Res 2006; 26: 2989-2993.
25. Zhou Q, Liu LZ, Fu B, Hu X, Shi X, Fang J, Jiang BH,. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis 2007; 28: 28-37.
26. Horiuchi A, Imai T, Shimizu M, Oka K, Wang C, Nikado T, Konishi I,. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells. Anticancer Res 2002; 22: 2697-2702.
27. Lee M, Hwang JT, Yun H, Kim EJ, Kim MJ, Kim SS, Ha J,. Critical roles of AMP-activated protein kinase in the carcinogenic metal-induced expression of VEGF and HIF-1 proteins in DU145 prostate carcinoma. Biochem Pharmacol 2006; 72: 91-103.
28. Wenger RH, Stiehl DP, Camenisch G,. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 2005: re12.
29. Chen KF, Lai YY, Sun HS, Tsai SJ,. Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha. Nucleic Acids Res 2005; 33: 5190-5198.
30. Kaluz S, Kaluzova M, Stanbridge EJ,. Regulation of gene expression by hypoxia: Integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta 2008; 395: 6-13.